The UPC recently rejected a PI application by Ballinno against the Union of European Football Associations for the use of VAR technology at the European Championship in Germany.
The recent decision in T 0209/22 by the EPO Technical Board of Appeal, highlights the different thresholds for novelty and sufficiency in relation to a medical use claim.
In decision T 1437/21, the Board of Appeal held that documents reporting the successful completion of a clinical trial involving the use of a medicine do not render the invention obvious.
The UK Court of Appeal has upheld the High Court decision that communications made using the Amazon IP rights notification and takedown system were unjustified threats of intellectual property litigation.
The Court of Appeal has dismissed Tesco’s appeal against the findings of trademark infringement and passing off.
From 1 April 2024, the European Patent Office (EPO) is offering reduced official fees for micro-entities.
On the 27th February 2024 the Court of Justice of the European Union (CJEU) issued a decision on priority rights of Community Designs in the EU.
In decision T 1252/20, the EPO has broadened the ability to protect known substances or compositions, for use in medicine.
Cleveland Scott York announces the next in its series of webinars - on the Madrid system for international trade mark filing